Neurotherapeutics Ltd have now produced 80 prototype wearable medical devices for use in a UK-wide trial

Neurotherapeutics Ltd have now produced 80 prototype wearable medical devices for use in a UK-wide randomised double-blind placebo-controlled trial investigating the efficacy of rhythmic median nerve stimulation in suppressing the urge-to-tic in Tourette syndrome.

MHRA approval for the clinical trial has been obtained as has NHS ethical approval. The trial, which is a collaboration between the University of Nottingham, NUH NHS Trust, and Neurotherapeutics Ltd, commenced in March 2022.